Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Taxane‐based Chemohormonal Therapy for Metastatic Hormone‐sensitive Prostate Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439794/all/images/google-play-badge.png. Accessed 16 May 2024.
Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439794/all/images/google-play-badge.png. Accessed May 16, 2024.
Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439794/all/images/google-play-badge.png
Taxane‐based Chemohormonal Therapy for Metastatic Hormone‐sensitive Prostate Cancer [Internet]. In: Cochrane Abstracts. [cited 2024 May 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439794/all/images/google-play-badge.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Taxane‐based chemohormonal therapy for metastatic hormone‐sensitive prostate cancer
ID - 439794
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439794/all/images/google-play-badge.png
DB - Evidence Central
DP - Unbound Medicine
ER -